Description
EyeArt by Eyenuk is a pioneering autonomous AI system designed to screen for diabetic retinopathy. It is the first and only FDA 510(k)-cleared AI technology for the autonomous detection of both more than mild and vision-threatening diabetic retinopathy (vtDR). EyeArt operates with a sensitivity of 96-97% and specificity of 88-90%, ensuring accurate and reliable results. The system is designed for use in primary care, endocrinology, optometry, and ophthalmology settings, providing a non-invasive retinal exam without the need for specialist oversight or patient dilation.
Read More
EyeArt's AI technology enables rapid screening, delivering diagnostic results in under 10 seconds. This allows healthcare providers to make immediate clinical decisions and prioritize high-risk patients for specialist referrals. The system is compatible with multiple camera models from leading manufacturers, offering flexibility and ease of integration into existing clinical workflows.
Eyenuk's EyeArt is also compliant with GDPR, HIPAA, and SOC 2 Type 2 standards, ensuring the highest levels of data security and privacy. The platform supports seamless EHR integration, minimizing administrative burdens and enhancing operational efficiency. EyeArt's capabilities extend beyond diabetic retinopathy, with the potential to detect age-related macular degeneration (AMD) and glaucomatous optic nerve damage.
The EyeArt system is globally recognized, with clearances from the EU MDR, Health Canada, and other regulatory bodies. It is designed to improve healthcare access and outcomes, particularly in underserved communities, by providing timely and accurate eye health assessments. EyeArt's autonomous AI technology represents a significant advancement in the early detection and management of diabetic retinopathy, helping to prevent vision loss and improve patient care.
- CategoryMedical & Clinical AI
- Pricing ModelContact sales
- DeploymentCloud
- PlatformsWeb
EyeArt AI Screening Tool's Core Features
FDA 510(k)-cleared for diabetic retinopathy
96-97% sensitivity for vtDR detection
Non-invasive retinal exams
No specialist required
Compatible with multiple camera models
GDPR, HIPAA, SOC 2 Type 2 compliant
Seamless EHR integration
Global regulatory clearances
How to use EyeArt AI Screening Tool?
Capture: Take retinal images using compatible cameras
Upload: Transfer images to the EyeArt system
Analyze: AI processes images in under 10 seconds
Report: Receive diagnostic results instantly
EyeArt AI Screening Tool's Use Cases
- Primary Care Screening
- Specialist Referral
- EHR Integration
- Non-Invasive Exams
- Global Health Access
